Featured Research

from universities, journals, and other organizations

Identifying lung cancer gene markers shows promise in identifying patients needing chemo

Date:
December 9, 2010
Source:
American Society for Radiation Oncology
Summary:
Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery, according to a new study.

Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery, according to a study presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.

This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.

Lung cancer is the leading cause of cancer deaths in the United States with about 170,000 new cases diagnosed annually. NSCLC accounts for 85 percent of lung cancer cases and has a five-year survival rate of only 15 percent. The standard of care for patients with stage II/IIIA disease is surgery plus chemotherapy. However, chemotherapy is not routinely offered to patients with stage I disease even though 30 percent or more will experience a relapse within five years. Doctors have been trying to identify ways to determine which of these stage I patients will relapse and thus may benefit from more aggressive treatment.

Lance Miller, Ph.D., and Jimmy Ruiz, M.D., at Wake Forest University School of Medicine, focus on NSCLC at the molecular level using a genomic tool referred to as a DNA microarray to study how genes are turned on and off in tumors. Using computational and statistical methods, they sift through the "gene profiles" of many tumors for molecular clues that may explain the different clinical behaviors of NSCLC. Recently, Dr. Miller and Dr. Ruiz studied, in combination, the gene profiles of hundreds of stage I non-small cell lung tumors obtained from various medical institutions around the world. They discovered a six-gene prognostic classifier that stratified patients into low-, intermediate- and high-risk groups with significantly different relapse rates.

The six-gene, stage I NSCLC classifier (aka, the "S1N" classifier) was then validated in a 179-patient test cohort not involved in the gene discovery process. While the predicted low- and intermediate-risk cases showed similar survival rates, the high-risk, "poor outcome" group showed strong agreement with the training cohort with a five-year relapse rate of greater than 80 percent. From this, investigators were able to conclude that surgery followed by observation is not sufficient treatment for these high-risk stage I patients, who comprised approximately one-third of the patient population.

"The goal of the project was to develop a personalized approach to the selection of patients with early stage lung cancer for whom more aggressive therapy may provide a survival benefit," Dr. Ruiz, lead author of the study and fellow of hematology and oncology at Wake Forest University School of Medicine, said. "While the S1N classifier still requires prospective validation, we believe it identifies a substantial fraction of high-risk stage I patients for whom chemotherapy or investigational treatments should be considered."


Story Source:

The above story is based on materials provided by American Society for Radiation Oncology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Radiation Oncology. "Identifying lung cancer gene markers shows promise in identifying patients needing chemo." ScienceDaily. ScienceDaily, 9 December 2010. <www.sciencedaily.com/releases/2010/12/101209101354.htm>.
American Society for Radiation Oncology. (2010, December 9). Identifying lung cancer gene markers shows promise in identifying patients needing chemo. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2010/12/101209101354.htm
American Society for Radiation Oncology. "Identifying lung cancer gene markers shows promise in identifying patients needing chemo." ScienceDaily. www.sciencedaily.com/releases/2010/12/101209101354.htm (accessed April 16, 2014).

Share This



More Health & Medicine News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com
Cognitive Function: Is It All Downhill From Age 24?

Cognitive Function: Is It All Downhill From Age 24?

Newsy (Apr. 15, 2014) A new study out of Canada says cognitive motor performance begins deteriorating around age 24. Video provided by Newsy
Powered by NewsLook.com
How Mt. Everest Helped Scientists Research Diabetes

How Mt. Everest Helped Scientists Research Diabetes

Newsy (Apr. 15, 2014) British researchers were able to use Mount Everest's low altitudes to study insulin resistance. They hope to find ways to treat diabetes. Video provided by Newsy
Powered by NewsLook.com
Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Newsy (Apr. 14, 2014) Richard van As lost all fingers on his right hand in a woodworking accident. Now, he's used the incident to create a prosthetic to help hundreds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins